JPMorgan Chase & Co’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-305,059
| Closed | -$7.35M | – | 6444 |
|
|
2023
Q1 | $7.35M | Buy |
305,059
+265,755
| +676% | +$6.4M | ﹤0.01% | 2209 |
|
|
2022
Q4 | $416K | Buy |
39,304
+1,880
| +5% | +$19.9K | ﹤0.01% | 3852 |
|
|
2022
Q3 | $168K | Buy |
37,424
+4,574
| +14% | +$20.5K | ﹤0.01% | 4243 |
|
|
2022
Q2 | $132K | Sell |
32,850
-2,009
| -6% | -$8.07K | ﹤0.01% | 4514 |
|
|
2022
Q1 | $255K | Buy |
34,859
+6,280
| +22% | +$45.9K | ﹤0.01% | 4326 |
|
|
2021
Q4 | $160K | Buy |
28,579
+2,109
| +8% | +$11.8K | ﹤0.01% | 4642 |
|
|
2021
Q3 | $169K | Buy |
26,470
+1,084
| +4% | +$6.92K | ﹤0.01% | 4492 |
|
|
2021
Q2 | $213K | Buy |
25,386
+4,493
| +22% | +$37.7K | ﹤0.01% | 4468 |
|
|
2021
Q1 | $220K | Sell |
20,893
-1,206
| -5% | -$12.7K | ﹤0.01% | 4418 |
|
|
2020
Q4 | $374K | Buy |
22,099
+4,355
| +25% | +$73.7K | ﹤0.01% | 3906 |
|
|
2020
Q3 | $226K | Buy |
17,744
+3,486
| +24% | +$44.4K | ﹤0.01% | 3684 |
|
|
2020
Q2 | $201K | Buy |
+14,258
| New | +$201K | ﹤0.01% | 3660 |
|
|
2019
Q1 | – | Sell |
-60
| Closed | – | – | 5032 |
|
|
2018
Q4 | $0 | Buy |
+60
| New | – | ﹤0.01% | 5035 |
|